Fasiha Kanwal News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Fasiha kanwal. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Fasiha Kanwal Today - Breaking & Trending Today
WASHINGTON — Glucagon-like peptide-1 receptor agonists were associated with lower risk for progression to cirrhosis and hepatocellular carcinoma in patients with metabolic dysfunction-associated steatotic liver disease and type 2 diabetes. “Metabolic dysfunction-associated steatotic liver disease, or MASLD, is a growing cause of cirrhosis and HCC,” Fasiha Kanwal, MD, MSHS, ....
Patients with cirrhosis had greater health care costs than matched controls, attributed mostly to cirrhosis complications and high inpatient utilization in the first year after diagnosis. ....
/PRNewswire/ Real-world evidence (RWE) leader Target RWE announced today that the CQC and TARGET-Liver Disease (LD) partnership with the American. ....
During the pandemic, American Indian and Alaska Native populations experienced nearly six times the mortality of white people from alcohol-associated liver disease. ....